This sounds too good to be true.
BCG is first and foremost the world’s most common tuberculosis vaccine, and was first used in humans all the way back in 1921. Made from a weakened strain of live bovine tuberculosis bacteria, it’s been show to be up to 80 percent effective in preventing TB for a duration of 15 years, depending on geographical location. That’s pretty impressive, which is why—US aside—it’s shoved into many a childhood arm around the world. But that’s just the beginning.
Cancer killer
Jumping from TB to cancer is quite a leap, but it’s one BCG has made time and again. As far back as 1979, a clinical trial declared that “BCG is beneficial in the treatment of lung cancer”. Then, in 1991, a study published in the new England Journal of Medicine suggested that the BCG vaccine offered strong protection against the recurrence of bladder cancer.
There’s a lot more, and if the article’s to be believed, we’ve barely scratched the surface of what the drug can do.
